Edwards Lifesciences (EW) Curent Deferred Tax Liability (2011 - 2014)

Edwards Lifesciences' Curent Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $8.3 million for Q4 2014.

• On a quarterly basis, Curent Deferred Tax Liability rose 15.28% year-over-year to $8.3 million in Q4 2014; TTM through Dec 2014 was $8.3 million, a 15.28% increase from a year earlier, with the FY2014 full-year figure at $8.3 million, up 15.28% from the prior year.
• Curent Deferred Tax Liability improved to $8.3 million in Q4 2014 per EW's latest filing, from $7.1 million in the prior quarter.
• Across five years, Curent Deferred Tax Liability topped out at $8.7 million in Q4 2012 and bottomed at $7.1 million in Q3 2014.
• The 4-year median for Curent Deferred Tax Liability is $8.3 million (2014), against an average of $8.0 million.
• Across the five-year window, Curent Deferred Tax Liability fell 17.24% in 2013 and grew 15.28% in 2014, its largest moves.
• Year by year, Curent Deferred Tax Liability stood at $8.6 million in 2011, then increased by 1.16% to $8.7 million in 2012, then decreased by 17.24% to $7.2 million in 2013, then increased by 15.28% to $8.3 million in 2014.
• Per Business Quant, the three latest EW Curent Deferred Tax Liability figures stand at $8.3 million (Q4 2014), $7.1 million (Q3 2014), and $7.2 million (Q4 2013).